| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Director, 10% Owner | 10% Owner
14 companies
Mott David M is a Director, 10% Owner at ADAPY with holdings across 14 companies. Recent SEC Form 4 filings include 16 buys and 5 sells.
Estimated insider holdings value: $1223.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 23, 2022 | ELVN Enliven Therapeutics, Inc. | Director | Buy | 151,472 | $1.45 | $219,667.14 | +37.9% | -14.5% | +335.9% | |
| Feb 17, 2022 | ELVN Enliven Therapeutics, Inc. | Director | Buy | 45,926 | $1.19 | $54,673.35 | +31.4% | -0.8% | +327.6% | |
| Feb 14, 2022 | ELVN Enliven Therapeutics, Inc. | Director | Buy | 31,826 | $1.23 | $39,246.16 | +99.2% | +3.5% | +382.6% | |
| Sep 23, 2021 | NVAX Novavax Inc | Director | Sell | 24,961 | $252.90 | $6,312,616.20 | -9.6% | -28.8% | -91.8% | |
| Dec 10, 2020 | ARDX Ardelyx, Inc. | Director | Buy | 170,000 | $5.89 | $1,000,841.00 | +68.7% | - | - | |
| Jun 25, 2020 | ARDX Ardelyx, Inc. | Director | Buy | 140,971 | $6.85 | $965,902.44 | +49.4% | - | - | |
| Jun 22, 2020 | ARDX Ardelyx, Inc. | Director | Buy | 4,673 | $6.75 | $31,524.99 | +4.6% | - | - | |
| Apr 7, 2020 | Director | Buy | 538,599 | $5.59 | $3,010,768.41 | New | - | - | ||
| Jan 24, 2020 | Director, 10% Owner | Buy | 7,500,000 | $0.67 | $5,000,250.00 | +62.5% | - | - | ||
| Jul 22, 2019 | MIRM Mirum Pharmaceuticals, Inc. | 10% Owner | Buy | 450,000 | $15.00 | $6,750,000.00 | +12.0% | - | - |